tiprankstipranks
Trending News
More News >
Tenax Therapeutics (TENX)
NASDAQ:TENX
US Market
Advertisement

Tenax Therapeutics (TENX) Drug Pipeline

Compare
589 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Tnx-103
Pulmonary Hypertension
Phase III
Recruiting
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Aug 01, 2023
Levosimendan 2.5 Mg/Ml Injectable Solution
Heart Failure With Normal Ejection Fraction, Hypertension Pulmonary Secondary Heart Failure, Right Sided Heart Failure With Normal Ejection Fraction
Phase II
Completed
Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients
Jul 24, 2018
Levosimendan
Hypertension Pulmonary Secondary, Heart Failure, Right Sided, Heart Failure With Normal Ejection Fraction
Phase II
Completed
Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF
May 03, 2018

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Tenax Therapeutics (TENX) have in its pipeline
      TENX is currently developing the following drugs: Tnx-103, Levosimendan 2.5 Mg/Ml Injectable Solution, Levosimendan. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis